Please use this identifier to cite or link to this item: doi:10.22028/D291-42284
Title: Characterization and Metabolism of Drug Products Containing the Cocaine-Like New Psychoactive Substances Indatraline and Troparil
Author(s): Manier, Sascha K.
Mumber, Paula
Zapp, Josef
Eckstein, Niels
Meyer, Markus R.
Language: English
Title: Metabolites
Volume: 14
Issue: 6
Publisher/Platform: MDPI
Year of Publication: 2024
Free key words: HPLC-HRMS/MS
new psychoactive substances
indatraline
troparil
metabolism
DDC notations: 500 Science
Publikation type: Journal Article
Abstract: With a rising demand of cocaine over the last years, it is likely that unregulated new psychoactive substances with similar effects such as indatraline ((1R,3S)-3-(3,4-dichlorophenyl)- N-methyl-2,3-dihydro-1H-inden-1-amine) and troparil (Methyl (1R,2S,3S,5S)-8-methyl-3-phenyl-8- azabicyclo[3.2.1]octane-2-carboxylate) become popular as well. Both substances share a similar pharmacological profile as cocaine, while their potency is higher, and their duration of action is longer. This study investigated their metabolic fate in rat urine and incubations using pooled human liver S9 fraction (pHLS9). Indatraline formed two phase I and four phase II metabolites, with aromatic hydroxylation and glucuronidation being the main metabolic steps. All metabolites were detected in rat urine, while the parent compound was not detectable. Although low in abundance, indatraline metabolites were well identifiable due to their specific isotopic patterns caused by chlorine. Troparil formed four phase I and three phase II metabolites, with demethylation being the main metabolic step. Hydroxylation of the tropane ring, the phenyl ring, and combinations of these steps, as well as glucuronidation, were found. Phase I metabolites were detectable in rat urine and pHLS9, while phase II metabolites were only detectable in rat urine.
DOI of the first publication: 10.3390/metabo14060342
URL of the first publication: https://doi.org/10.3390/metabo14060342
Link to this record: urn:nbn:de:bsz:291--ds-422849
hdl:20.500.11880/37982
http://dx.doi.org/10.22028/D291-42284
ISSN: 2218-1989
Date of registration: 1-Jul-2024
Description of the related object: Supplementary Materials
Related object: https://www.mdpi.com/article/10.3390/metabo14060342/s1
Faculty: M - Medizinische Fakultät
NT - Naturwissenschaftlich- Technische Fakultät
Department: M - Experimentelle und Klinische Pharmakologie und Toxikologie
NT - Pharmazie
Professorship: M - Prof. Dr. Markus Meyer
NT - Prof. Dr. Alexandra K. Kiemer
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
File Description SizeFormat 
metabolites-14-00342-v2.pdf1,32 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons